NEW YORK (GenomeWeb News) – The Burnham Institute for Medical Research will use Labcyte’s Echo liquid handlers in two of its laboratories for research in cancer, neurological diseases, aging, diabetes, and obesity, Labcyte said this week.
Labcyte said the agreement is worth $2.3 million and that the systems will be delivered in about six months.
Burnham will use the liquid handlers in facilities in La Jolla, Calif., and Lake Nona, Fla., as part of the National Institutes of Health’s Molecular Libraries Screening Centers Network. The institute is one of 10 screening centers under the NIH Roadmap initiative.
The institute will use the Echo systems for compound plate-to-plate transfer, reformatting, dose-response experiments, and hit picking.
Financial terms of the agreement were not released.